Patent · US Active

Tissue engineered nucleus pulposus replacement

US9005289B1 · kind B1 · utility

5Cited by
3References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2012
Grant dateApr 14, 2015
Priority date
Expiry dateOct 11, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/38
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A nucleus pulposus replacement is described that includes a containment balloon that can sequester synthetic and/or tissue engineered fill material(s) in the nucleus pulposus region of the IVD thus mitigating migration and expulsion of the fill materials. The containment balloon can be formed of a biocompatible material that includes the structural proteins elastin and collagen. The containment balloon is joined to a closure device that can be used to deliver a fill material, e.g., a hydrogel, to the interior of the containment balloon following implantation of the replacement device in the intervertebral disc area.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.